January 5, 2001 - Volume 15 - Issue 1
pp: N1-N2,F1-F9,1-141

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

Murphy, Robert L.; Brun, Scott; Hicks, Charles; More

AIDS . 15(1):F1-F9, January 5, 2001.

Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2

Abbate, Isabella; Dianzani, Ferdinando; Turriziani, Ombretta; More

AIDS . 15(1):11-16, January 5, 2001.

Concise Communication

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy

Jouan, Marc; Savès, Marianne; Tubiana, Roland; More

AIDS . 15(1):23-31, January 5, 2001.

Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy

Goebel, Frank-D.; Hemmer, Robert; Schmit, Jean-Claude; More

AIDS . 15(1):33-45, January 5, 2001.

Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette–Guérin (BCG) among HIV-positive children and adults in Zambia

Waddell, Richard D.; Lishimpi, Kennedy; von Reyn, C. Fordham; More

AIDS . 15(1):55-60, January 5, 2001.

Concise Communication

Concise Communication

The ADAM study continued: maintenance therapy after 50 weeks of induction therapy

Reijers, Monique H. E.; Weverling, Gerrit Jan; Jurriaans, Suzanne; More

AIDS . 15(1):129-131, January 5, 2001.

1 2 3 4 5